Promethera Biosciences Successfully Enrolls Twenty Patients in its Multicentric Phase I

Promethera Biosciences has conducted the trial in Belgium, France, United Kingdom, Italy and Israel, treating 20 patients affected by very rare liver-based metabolic diseases.
FirstWord MedTech